|
000
| 01328nam 2200277za 4500 |
|---|
| 001 | 9.808387 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107140352 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 151230s1994 onc |o f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/67-3-1994E-PDF |
|---|
| 245 | 10|aStability testing of new drug substances and products |h[electronic resource]. |
|---|
| 246 | 3 |iAt head of title: |aICH harmonised tripartite guideline, International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use |
|---|
| 260 | |aOttawa : |bHealth Protection Branch, Health Canada, |cc1994. |
|---|
| 300 | |aii, 12 p. |
|---|
| 490 | 1 |aDrugs Directorate guidelines |
|---|
| 500 | |a"ICH harmonised tripartite guideline, International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use." |
|---|
| 500 | |aThe catalogue number (H42-2/67/3-1994E) for the print edition has been copied in this electronic publication. |
|---|
| 500 | |a"Fall 1994." |
|---|
| 692 | 07|2gccst|aDrugs |
|---|
| 692 | 07|2gccst|aTesting |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 830 | #0|aDrugs Directorate guidelines ;|v67/3-1994|w(CaOODSP)9.808752 |
|---|
| 856 | 40|qPDF|s880 KB|uhttps://publications.gc.ca/collections/collection_2015/sc-hc/H42-2-67-3-1994-eng.pdf |
|---|